News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

REVA Medical to Market Fantom Scaffold Directly After Boston Scientific (BSX) Failed to Exercise Option to Distribute



8/4/2017 10:27:54 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
REVA Medical (OTC:RVALL) launches its direct selling activities supporting its Fantom drug-eluting coronary scaffold after Boston Scientific allowed its exclusive right to negotiate for distribution to expire as specified under their 2007 agreement. The latter's election window was triggered earlier this year when REVA delivered positive clinical data supporting the performance of the device.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES